LTR 97: Surviving chaos and uncertainty at the FDA

This is a free preview of a paid episode. To hear more, visit naveenagarwalphd.substack.com

Summary

“More importantly than ever, a good product development and risk-based approach is going to be critical.”

In this episode of the Let's Talk Risk Podcast, Naveen Agarwal and Michael Nilo discuss the current state of the FDA amidst significant staff cuts and organizational chaos. They explore the implications for regulatory affairs professionals, t…